Company Overview

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

  • Name

    Avantor, Inc.

  • CEO

    Mr. Michael Stubblefield

  • Website

    www.avantorsciences.com

  • Sector

    Life Sciences Tools and Services

  • Year Founded

    1904

Profile

  • Market Cap

    $18.27B

  • EV

    $23.09B

  • Shares Out

    679.84M

  • Revenue

    $6,825.6M

  • Employees

    14,500

Margins

  • Gross

    33.71%

  • EBITDA

    16.96%

  • Operating

    11.08%

  • Pre-Tax

    6.61%

  • Net

    5.28%

  • FCF

    10.79%

Returns (5Yr Avg)

  • ROA

    2.91%

  • ROTA

    -0.09%

  • ROE

    9.28%

  • ROCE

    8.6%

  • ROIC

    8.08%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $28.57

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $287.5M

  • Net Debt

    $4,827.5M

  • Debt/Equity

    0.94

  • EBIT/Interest

    2.22

Growth (CAGR)

  • Rev 3Yr

    -1.03%

  • Rev 5Yr

    2.68%

  • Rev 10Yr

  • Dil EPS 3Yr

    4.7%

  • Dil EPS 5Yr

    -29.9%

  • Dil EPS 10Yr

  • Rev Fwd 2Yr

    2.14%

  • EBITDA Fwd 2Yr

    2.97%

  • EPS Fwd 2Yr

    7.08%

  • EPS LT Growth Est

    12.24%

Dividends

  • Yield

  • Payout

  • DPS

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

NYSE:AVTR